Filing Flows › Staar Surgical (STAA) › Capital expenditures
Staar Surgical (STAA) capital expenditures by quarter
Staar Surgical's capital expenditures were $935K in Q3 2026 (third quarter 2026), +89% from Q2 2026. Over the last 3 quarters it ranged from $494K (Q2 2026) to $935K (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $935K | +89% | +6% |
| Q2 2026 | $494K | -44% | — |
| Q3 2025 | $883K | — | — |
Q3 2026 at a glance
Staar Surgical, Q3 2026: revenue $83.4M (-12% year over year), operating margin 6.5%, net earnings $5.6M, operating cash flow $27.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Staar Surgical's capital expenditures?
Staar Surgical's capital expenditures were $935K in Q3 2026 (third quarter 2026), +89% from Q2 2026.
How has Staar Surgical's capital expenditures changed?
Over the last 3 quarters it ranged from $494K (Q2 2026) to $935K (Q3 2026).